endocannabinoid system clinical research: REAL 2.0 Study
Clinical Takeaway The REAL 2.0 study tracked Canadian youth over 15 years to examine how early adolescent factors like body image and disordered eating contribute to mental health and substance use outcomes in early adulthood. Findings from this cohort…
Endocannabinoid System Clinical Research: Minder RCT Insights
This article reviews endocannabinoid system clinical research RCT findings from the Minder app trial. The study evaluated digital interventions for mental health and substance use in university students. Results highlight the app's potential to improve…
Cannabinoids in Pediatric Care: Evidence-Based Clinical Review
Cannabinoid use in children is an evolving area with limited rigorous evidence. Most data comes from observational studies rather than controlled trials. This review highlights the current clinical evidence and safety considerations for cannabinoids in…
CED Cannabis Research Digest — February 27, 2026
The cannabis medicine research digest for February 27, 2026, highlights key peer-reviewed studies scored for clinical relevance. This weekly digest provides a curated summary of cannabis research to inform patient care. Stay updated with the latest…
`Endocannabinoid System Research: Cannabis for PTSD & SUD`
Clinical Takeaway Trauma-focused treatments remain effective for PTSD even when patients are actively using cannabis, including those with co-occurring substance use disorders. Clinicians should not withhold or delay evidence-based PTSD care based on a…
Cannabinoid Clinical Trials: Cannabis in Student Mental Health
This randomized controlled trial evaluates a digital mental health intervention students can access during the critical university transition. The study focuses on cannabis and other substance use alongside mental health outcomes. Results highlight the…
Clinical Research on Mental Health in Retired Athletes
Mental health retired athletes face elevated rates of depression, anxiety, and cognitive concerns compared to the general population. Clinical research highlights factors like career-ending injuries and repeated head trauma as key influences. Early…
Endocannabinoid System Research: Cannabis & Autism Risk
Peripregnancy cannabis exposure autism risks have been linked to behavioral and developmental differences in children. Research shows varying effects depending on autism spectrum disorder symptoms. This highlights concerns about cannabis use from…
Endocannabinoid System & GLP-1 Receptor Mental Health Evidence
GLP-1 receptor agonists mental health impact has been studied using genetic analysis data. These medications may influence risk for certain psychiatric disorders, including schizophrenia. Patients and clinicians should consider the mental health…
Cannabinoid Clinical Trials: Cannabis Intervention in Teens
Clinical Takeaway Tailored cannabis prevention messaging that first addresses and refutes adolescents’ negative reactions to anti-cannabis appeals, then delivers a third targeted communication, shows promise as a more effective approach than…
